Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chalmers

Showing results (81-90 of 646) with videos related to

Pageof 65
Sort By:
The European Respiratory Journal|January 4, 2024
<i>ERJ</i> 2024: your journal, my journal, our journalDon D Sin, James D Chalmers
Chest|November 7, 2022
COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? NoHolly R Keir, James D Chalmers
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
A new anti-inflammatory treatment for bronchiectasis: a viewpoint on optimal dose selection for DPP1 inhibition in clinical practiceJames D Chalmers, Charles L Daley
American Journal of Respiratory and Critical Care Medicine|July 1, 2024
The Precision Medicine Era of BronchiectasisSanjay H Chotirmall, James D Chalmers
European Respiratory Review : an Official Journal of the European Respiratory Society|February 24, 2022
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapyHolly R Keir, James D Chalmers
Journal of Law and Medicine|July 16, 2002
Consent, commercialisation and benefit-sharingD Nicol, M Otlowski, D Chalmers
Chest|November 7, 2022
Rebuttal From Dr Keir and Prof ChalmersHolly R Keir, James D Chalmers
Critical Care Medicine|May 16, 2015
Middle East respiratory syndrome: the need for better evidence in severe respiratory viral infectionsHani Abo-Leyah, James D Chalmers
BMC Pulmonary Medicine|May 24, 2018
Bronchiectasis: an emerging global epidemicSanjay H Chotirmall, James D Chalmers
Chest|December 11, 2017
Bronchiectasis Management: The State of the UnionJames D Chalmers, Marcos I Restrepo
Pageof 65

Showing results (81-90 of 646) with videos related to

Sort By:
Pageof 65
The European Respiratory Journal|January 4, 2024
<i>ERJ</i> 2024: your journal, my journal, our journalDon D Sin, James D Chalmers
Chest|November 7, 2022
COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? NoHolly R Keir, James D Chalmers
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
A new anti-inflammatory treatment for bronchiectasis: a viewpoint on optimal dose selection for DPP1 inhibition in clinical practiceJames D Chalmers, Charles L Daley
American Journal of Respiratory and Critical Care Medicine|July 1, 2024
The Precision Medicine Era of BronchiectasisSanjay H Chotirmall, James D Chalmers
European Respiratory Review : an Official Journal of the European Respiratory Society|February 24, 2022
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapyHolly R Keir, James D Chalmers
Journal of Law and Medicine|July 16, 2002
Consent, commercialisation and benefit-sharingD Nicol, M Otlowski, D Chalmers
Chest|November 7, 2022
Rebuttal From Dr Keir and Prof ChalmersHolly R Keir, James D Chalmers
Critical Care Medicine|May 16, 2015
Middle East respiratory syndrome: the need for better evidence in severe respiratory viral infectionsHani Abo-Leyah, James D Chalmers
BMC Pulmonary Medicine|May 24, 2018
Bronchiectasis: an emerging global epidemicSanjay H Chotirmall, James D Chalmers
Chest|December 11, 2017
Bronchiectasis Management: The State of the UnionJames D Chalmers, Marcos I Restrepo
Pageof 65